… In addition to dopaminergic neuropathology, there is … with dopamine system dysfunction
and/or dopaminergic neuronal … process affecting dopaminergic and non-dopaminergic systems (…

… to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. …
AJ Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine …

… dosing and sedation, we reduce or change the offending drug. We compromise motor control
by reducing dopaminergic drugs only among the subset of patients with intolerance to all …

… The role of dopaminergic drugs in treating the various non-… In this Review, we investigate
the dopaminergic basis of the … in part, with various dopaminergic strategies and, where relevant…

… In order to evaluate the relationship between the dose of dopaminergic drugs and the
development of an ICRB, we conducted three separate multivariate logistic regression analyses. …

… ) in patients with Parkinson disease have … dopaminergic stimulation, or using novel agents
that target receptors implicated in the mechanisms underlying LIDs. Treatment with dopamine …

… centrally to dopamine, replacing the neurotransmitter deficient in Parkinson disease. Outside
the blood-brain barrier, in the peripheral circulation, dopamine decarboxylase inhibitors (…

… to take dopaminergic drugs becomes pathologically … leads to compulsive dopaminergic drug
use 1,2 —the dopamine … brain dopamine systems mediating reward by dopaminergic drugs …

… How the actions of dopaminergic drugs produce side effects and how … Dopaminergic drugs,
levodopa and dopamine agonists, are highly effective in the treatment of Parkinson's disease …

… Continuous dopaminergic stimulation is a therapeutic strategy … of Parkinson's disease, which
proposes that dopaminergic agents that provide continuous stimulation of striatal dopamine …